TAK logo

TAK Accounts receivable

Annual accounts receivable:

$4.36B+$309.48M(+7.65%)
March 1, 2025

Summary

  • As of today (September 18, 2025), TAK annual accounts receivable is $4.36 billion, with the most recent change of +$309.48 million (+7.65%) on March 1, 2025.
  • During the last 3 years, TAK annual accounts receivable has fallen by -$731.56 million (-14.38%).
  • TAK annual accounts receivable is now -31.96% below its all-time high of $6.40 billion, reached on March 31, 2021.

Performance

1-year change

+7.65%

3-year change

-14.38%

5-year change

-29.89%

15-year change

+28.39%

TAK Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.56%
TAK annual accounts receivable is higher than 96.56% of companies in Healthcare sector

Range

All-time high

$6.40B
TAK annual accounts receivable is currently -31.96% below its historical high of $6.40 billion

3-year low

$4.05B
TAK annual accounts receivable is currently +7.65% above its 3-year low

Earnings dates

Last annual earnings report date

Mar 1, 2025
TAK previous annual earnings announcement was published on Mar 1, 2025

Next annual earnings report date

N/A
TAK next annual earnings announcement has not yet been scheduled

OtherTAKbalance sheet metrics

annual accounts payable

$2.06B
TAK annual accounts payable is $2.06 billion

annual total assets

$95.28B
TAK annual total assets is $95.28 billion

annual total liabilities

$48.90B
TAK annual total liabilities is $48.90 billion

annual cash & cash equivalents

$2.58B
TAK annual cash & cash equivalents is $2.58 billion

Quarterly accounts receivable:

$4.61B+$252.08M(+5.79%)
June 1, 2025

Summary

  • As of today (September 18, 2025), TAK quarterly accounts receivable is $4.61 billion, with the most recent change of +$252.08 million (+5.79%) on June 1, 2025.
  • Over the past year, TAK quarterly accounts receivable has dropped by -$87.96 million (-1.87%).
  • TAK quarterly accounts receivable is now -39.89% below its all-time high of $7.67 billion, reached on December 31, 2020.

Performance

3-month change

+5.79%

1-year change

-1.87%

3-year change

-17.86%

5-year change

-36.64%

TAK Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.6%
TAK quarterly accounts receivable is higher than 96.6% of companies in Healthcare sector

Range

All-time high

$7.67B
TAK quarterly accounts receivable is currently -39.89% below its historical high of $7.67 billion

3-year low

$4.05B
TAK quarterly accounts receivable is currently +13.88% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 1, 2025
TAK previous earnings announcement was published on Jun 1, 2025

Next quarterly earnings report date

Oct 30, 2025
TAK next earnings announcement is scheduled for Oct 30, 2025

OtherTAKbalance sheet metrics

quarterly accounts payable

$2.92B
TAK quarterly accounts payable is $2.92 billion

quarterly total assets

$96.95B
TAK quarterly total assets is $96.95 billion

quarterly total liabilities

$49.42B
TAK quarterly total liabilities is $49.42 billion

quarterly cash & cash equivalents

$2.42B
TAK quarterly cash & cash equivalents is $2.42 billion

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TAK Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.7%-1.9%
3 y3 years-14.4%-17.9%
5 y5 years-29.9%-36.6%

TAK Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.4%+7.7%-17.9%+13.9%
5 y5-year-32.0%+7.7%-39.9%+13.9%
alltimeall time-32.0%+154.9%-39.9%+44.1%

TAK Accounts receivable History

DateAnnualQuarterly
Jun 2025
-
$4.61B(+5.8%)
Mar 2025
$4.36B(+7.6%)
$4.36B(-3.8%)
Dec 2024
-
$4.53B(-7.6%)
Sep 2024
-
$4.90B(+4.3%)
Jun 2024
-
$4.70B(+16.1%)
Mar 2024
$4.05B(-6.4%)
$4.05B(-20.3%)
Dec 2023
-
$5.08B(+0.4%)
Sep 2023
-
$5.06B(-7.7%)
Jun 2023
-
$5.49B(+26.9%)
Mar 2023
$4.32B(-15.0%)
$4.32B(-19.3%)
Dec 2022
-
$5.36B(+2.1%)
Sep 2022
-
$5.25B(-6.4%)
Jun 2022
-
$5.61B(+10.3%)
Mar 2022
$5.09B(-20.5%)
$5.09B(-18.1%)
Dec 2021
-
$6.21B(-17.8%)
Sep 2021
-
$7.56B(+1.4%)
Jun 2021
-
$7.45B(+16.4%)
Mar 2021
$6.40B(+3.1%)
$6.40B(-16.5%)
Dec 2020
-
$7.67B(+7.3%)
Sep 2020
-
$7.14B(-1.8%)
Jun 2020
-
$7.27B(+17.1%)
Mar 2020
$6.21B(+4.6%)
$6.21B(-17.7%)
Dec 2019
-
$7.55B(+4.7%)
Sep 2019
-
$7.21B(+2.2%)
Jun 2019
-
$7.06B(+18.7%)
Mar 2019
$5.94B(+75.1%)
$5.94B(+28.0%)
Dec 2018
-
$4.64B(+14.3%)
Sep 2018
-
$4.06B(-0.2%)
Jun 2018
-
$4.07B(+19.9%)
Mar 2018
$3.39B(+6.1%)
$3.39B(-25.3%)
Dec 2017
-
$4.54B(+9.6%)
Sep 2017
-
$4.14B(+4.7%)
Jun 2017
-
$3.96B(+23.8%)
Mar 2017
$3.20B(-4.5%)
$3.20B(-23.9%)
Dec 2016
-
$4.20B(-2.5%)
Sep 2016
-
$4.31B(+3.6%)
Jun 2016
-
$4.16B(+24.2%)
Mar 2016
$3.35B
$3.35B(-16.7%)
Dec 2015
-
$4.02B(+2.1%)
Sep 2015
-
$3.94B(+4.5%)
DateAnnualQuarterly
Jun 2015
-
$3.77B(+12.8%)
Mar 2015
$3.34B(-8.4%)
$3.34B(-18.1%)
Dec 2014
-
$4.08B(-1.7%)
Sep 2014
-
$4.15B(-1.1%)
Jun 2014
-
$4.20B(+13.6%)
Mar 2014
$3.65B(+0.2%)
$3.69B(-8.3%)
Dec 2013
-
$4.03B(+3.5%)
Sep 2013
-
$3.89B(+6.4%)
Jun 2013
-
$3.66B(+0.5%)
Mar 2013
$3.64B(-12.3%)
$3.64B(-16.5%)
Dec 2012
-
$4.36B(+2.5%)
Sep 2012
-
$4.26B(+1.5%)
Jun 2012
-
$4.19B(+0.9%)
Mar 2012
$4.15B(+17.5%)
$4.15B(-14.3%)
Dec 2011
-
$4.85B(+7.2%)
Sep 2011
-
$4.52B(+22.2%)
Jun 2011
-
$3.70B(+4.7%)
Mar 2011
$3.54B(+18.1%)
$3.54B(-8.7%)
Dec 2010
-
$3.87B(+9.7%)
Sep 2010
-
$3.53B(+7.6%)
Jun 2010
-
$3.28B(-13.0%)
Mar 2010
$2.99B(-1.9%)
-
Mar 2009
$3.05B(+22.8%)
-
Dec 2008
-
$3.77B
Mar 2008
$2.48B(+12.2%)
-
Mar 2007
$2.21B(+10.5%)
-
Mar 2006
$2.00B(-4.9%)
-
Mar 2005
$2.11B(+4.5%)
-
Mar 2004
$2.02B(+18.0%)
-
Mar 2003
$1.71B(-3.6%)
-
Mar 2002
$1.77B(-12.6%)
-
Mar 2001
$2.03B(-10.9%)
-
Mar 2000
$2.28B(+19.5%)
-
Mar 1999
$1.91B(+10.3%)
-
Mar 1998
$1.73B(-14.0%)
-
Mar 1997
$2.01B(-17.1%)
-
Mar 1996
$2.42B(-13.7%)
-
Mar 1995
$2.81B(+25.4%)
-
Mar 1994
$2.24B(+22.6%)
-
Mar 1993
$1.83B(-1.7%)
-
Mar 1992
$1.86B
-

FAQ

  • What is Takeda Pharmaceutical Company Limited annual accounts receivable?
  • What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?
  • What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?
  • What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?

What is Takeda Pharmaceutical Company Limited annual accounts receivable?

The current annual accounts receivable of TAK is $4.36B

What is the all time high annual accounts receivable for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high annual accounts receivable is $6.40B

What is Takeda Pharmaceutical Company Limited annual accounts receivable year-on-year change?

Over the past year, TAK annual accounts receivable has changed by +$309.48M (+7.65%)

What is Takeda Pharmaceutical Company Limited quarterly accounts receivable?

The current quarterly accounts receivable of TAK is $4.61B

What is the all time high quarterly accounts receivable for Takeda Pharmaceutical Company Limited?

Takeda Pharmaceutical Company Limited all-time high quarterly accounts receivable is $7.67B

What is Takeda Pharmaceutical Company Limited quarterly accounts receivable year-on-year change?

Over the past year, TAK quarterly accounts receivable has changed by -$87.96M (-1.87%)
On this page